9 August 2018 NICM researchers have launched a new online resource aimed at reducing the incidence of undiagnosed menstrual disorders and improving the way young women learn about and deal with menstruation.
7 August 2018 Australians aged 40 and over with dementia are encouraged to participate in one of the nation’s largest clinical trials investigating a novel Chinese herbal extract Sailuotong. Conducted by NICM Health Research Institute, the Phase III clinical trial has added three new hospital sites across NSW, VIC and QLD, with further sites planned for SA and WA. The site expansion coincides with positive results from an independent clinical trial of SLT published in the recent journal Alzheimer's & Dementia.
20 July 2018 NICM researchers in partnership with UnityHealth will develop and disseminate objective evidence-based information on Chinese herb-drug interactions as part of UnityHealth's IMGateway service for healthcare professional and patients.
Bringing together Australia’s leading medicinal cannabis scientists, academics and educators, delegates will learn about the latest research, regulatory developments and education regarding medicinal cannabis.
The clinical trial of SLT for vascular dementia is a multicentre study to evaluate the effectiveness and safety of a standardised herbal medicine formula in patients with vascular dementia and Alzheimer's disease with cerebrovascular disease (mixed dementia). Read more about SLT for Vascular Dementia